Jun 15, 2026 08:05AM

Jun 15, 2026 08:05AM

Mar 26, 2026 09:24AM

Mar 26, 2026 09:23AM

Mar 17, 2026 08:25AM

Mar 17, 2026 08:25AM

Feb 17, 2026 11:32AM Moonage Media Spotlights Polyrizon (Nasdaq: PLRZ): Unveils NASARIX™, Drug-Free Allergy Blocker

Jan 22, 2026 09:25AM

Jan 22, 2026 09:25AM

Jan 2, 2026 08:32AM

Jan 2, 2026 08:30AM

Jan 2, 2026 08:30AM

Dec 8, 2025 08:56AM

Dec 8, 2025 08:55AM Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray

Dec 4, 2025 07:32AM

Dec 4, 2025 07:32AM

Sep 19, 2025 08:15AM

Sep 19, 2025 08:15AM

Apr 25, 2025 07:37AM

Apr 25, 2025 07:37AM

Mar 27, 2025 08:25AM Polyrizon Ltd (PLRZ) Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Mar 27, 2025 08:25AM

Mar 13, 2025 07:51AM

Mar 13, 2025 07:51AM

Mar 13, 2025 07:51AM

Mar 10, 2025 07:48AM

Mar 10, 2025 07:47AM

Mar 10, 2025 07:47AM Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All